
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
By law, Medicare will have to take a medication’s efficacy and its research and development…

By law, Medicare will have to take a medication’s efficacy and its research and development…

President Biden is banking on longtime bipartisan interest in eliminating cancer deaths to secure some…

WASHINGTON — All U.S. women getting mammograms will soon receive information about their breast density,…

Being physically active has been associated with lower risk for developing breast cancer. Now, a…

While aerobic activities like walking, jogging, gardening, swimming, and playing tennis or pickleball are an…

I’ve been taking vitamin C since the 1970s. Should I continue taking it? Should I…
.jpg)
Social Isolation Linked with Higher Risk of Dementia Older adults who are socially isolated have…

When transgender men transition, their risk for breast cancer tends to plummet and look more…

If you go to Amazon or search Google for weighted blankets, you will find many…

Locked behind the firewalls of proprietary systems sits a treasure trove of data that could…

Legend Biotech said Friday that its CAR-T therapy Carvykti kept multiple myeloma patients’ cancer in…

Emily was combing her baby daughter’s hair when she first felt the lumps. It was…
.jpg)
For many people, receiving a dire diagnosis or a confusing test result triggers the desire…

If you have been diagnosed with obstructive sleep apnea (OSA), your doctor likely has recommended…

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the…

Massachusetts General Hospital is launching a prospective trial of an artificial intelligence tool designed to…

SAN FRANCISCO — The team behind Rezo Therapeutics, a new biotech co-founded by a group…
.jpg)
On Target is a recurring feature from STAT that dives deep into the most promising…
.jpg)
Inflammation is a hot topic these days. With so many people suffering from chronic diseases,…
.jpg)
Where do new drugs come from? Does science need billionaires? And do normal people care…

On Target is a recurring feature from STAT that dives deep into the most promising…

SAN FRANCISCO — The last time Sana CEO Steve Harr was here for the J.P….

They’re far too small to be seen by even the most sophisticated medical imaging device….

SAN FRANCISCO — Invitae, a Bay Area genetic testing company with a mission to use…

SAN FRANCISCO — When BioNTech was founded in 2008, messenger RNA therapies and vaccines were…

WASHINGTON — Medicare officials have taken a step toward making a cutting-edge cancer treatment called…

For the third time in less than a year, a group of lawmakers is urging…

Much of the last decade felt like the golden age of biotechnology investing. Money —…

Day One Biopharmaceuticals said Sunday that a targeted therapy shrank tumors by at least 50%…
.jpg)
Geron Corporation, a biotech that made sci-fi-sounding headlines through the 90s and 2000s before shuffling…

With his Parker Institute for Cancer Immunotherapy, Sean Parker has been building a dream team…

Is the women’s restroom one of the first things you look for when you go…

CDC Reports Potential for Extreme Flu Season According to the Centers for Disease Control and…

Kite Pharma, Gilead’s cell therapy subsidiary, said on Tuesday it would buy Tmunity, a biotech…

Gilead Sciences and Arcus Biosciences said Monday that an experimental cancer immunotherapy directed against a…

Bay Area biotech Guardant Health on Thursday announced results from a massive trial of its…

If you search the internet for prostate health supplements, you will find dozens of options…

Editor’s Note: A livestream of the event will be embedded below at 1 p.m. ET. …

Medicines that reshape or tamp down immune responses may be life-changing for patients with cancer…

NEW ORLEANS – One of the best therapies for some types of lymphoma and leukemia…

An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant…

The Food and Drug Administration on Monday approved a second KRAS-blocking treatment for advanced lung…

NEW ORLEANS – An experimental immunotherapy from Affimed for patients with advanced Hodgkin lymphoma has…

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer…

NEW ORLEANS — Researchers had hoped in recent years that a protein called GPRC5D might…

Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food…

NEW ORLEANS — An emerging class of genetically targeted drugs is inducing remissions in about…

NEW ORLEANS — Adicet Bio generated a good deal of buzz last June with a…